Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Perez

Showing results (11-20 of 99) with videos related to

Pageof 10
Sort By:
Internal Medicine (Tokyo, Japan)|January 17, 2012
Isolated unilateral pulmonary artery agenesisEva Perez-Pampin, Joaquin Campos-Franco, Anxo Martinez-de Alegria, et al.
Arthritis and Rheumatism|January 20, 2004
A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosusLorena Fernandez-Blanco, Eva Perez-Pampin, Juan J Gomez-Reino, et al.
Rheumatology International|July 8, 2009
Oligo-secretory myeloma in a patient with ankylosing spondylitisEva Perez-Pampin, Joaquin Campos, Jorge Blanco, et al.
Arthritis and Rheumatism|June 8, 2012
Association of anti-citrullinated vimentin and anti-citrullinated α-enolase antibodies with subsets of rheumatoid arthritisAriana Montes, Eva Perez-Pampin, Manuel Calaza, et al.
Arthritis and Rheumatism|October 12, 2012
Reply: Pathogenic relevance of anti-citrullinated vimentin antibodies: comment on the article by Montes et alAriana Montes, Eva Perez-Pampin, Manuel Calaza, et al.
Arthritis Research & Therapy|April 29, 2010
Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only studyMarian Suarez-Gestal, Eva Perez-Pampin, Manuel Calaza, et al.
Rheumatology International|July 30, 2013
Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experienceJose Ramon Maneiro, Eva Perez-Pampin, Eva Salgado, et al.
Frontiers in Immunology|September 2, 2017
Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality ControlMichiel M Harmsen, Julian Seago, Eva Perez, et al.
Plos Pathogens|May 5, 2022
Foot-and-mouth disease virus localisation on follicular dendritic cells and sustained induction of neutralising antibodies is dependent on binding to complement receptors (CR2/CR1)Lucy Gordon, Neil Mabbott, Joanna Wells, et al.
Vaccine|July 25, 2021
The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East AfricaBen Jackson, Yongjie Harvey, Eva Perez-Martin, et al.
Pageof 10

Showing results (11-20 of 99) with videos related to

Sort By:
Pageof 10
Internal Medicine (Tokyo, Japan)|January 17, 2012
Isolated unilateral pulmonary artery agenesisEva Perez-Pampin, Joaquin Campos-Franco, Anxo Martinez-de Alegria, et al.
Arthritis and Rheumatism|January 20, 2004
A CTLA-4 polymorphism associated with susceptibility to systemic lupus erythematosusLorena Fernandez-Blanco, Eva Perez-Pampin, Juan J Gomez-Reino, et al.
Rheumatology International|July 8, 2009
Oligo-secretory myeloma in a patient with ankylosing spondylitisEva Perez-Pampin, Joaquin Campos, Jorge Blanco, et al.
Arthritis and Rheumatism|June 8, 2012
Association of anti-citrullinated vimentin and anti-citrullinated α-enolase antibodies with subsets of rheumatoid arthritisAriana Montes, Eva Perez-Pampin, Manuel Calaza, et al.
Arthritis and Rheumatism|October 12, 2012
Reply: Pathogenic relevance of anti-citrullinated vimentin antibodies: comment on the article by Montes et alAriana Montes, Eva Perez-Pampin, Manuel Calaza, et al.
Arthritis Research & Therapy|April 29, 2010
Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only studyMarian Suarez-Gestal, Eva Perez-Pampin, Manuel Calaza, et al.
Rheumatology International|July 30, 2013
Observational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experienceJose Ramon Maneiro, Eva Perez-Pampin, Eva Salgado, et al.
Frontiers in Immunology|September 2, 2017
Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality ControlMichiel M Harmsen, Julian Seago, Eva Perez, et al.
Plos Pathogens|May 5, 2022
Foot-and-mouth disease virus localisation on follicular dendritic cells and sustained induction of neutralising antibodies is dependent on binding to complement receptors (CR2/CR1)Lucy Gordon, Neil Mabbott, Joanna Wells, et al.
Vaccine|July 25, 2021
The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East AfricaBen Jackson, Yongjie Harvey, Eva Perez-Martin, et al.
Pageof 10